Medimab Biotherapeutics Opens Bespoke Laboratory Facilities, Created By Kadans Science Partner, At Abingdon Science Park, UK
- New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumours
- Kadans has also completed on Barton House, a new research and development facility on the Science Quadrant at Abingdon Science Park
MediMab Biotherapeutics, a subsidiary of MediMabBio, Inc., a South Korea-based biotechnology firm, announces that it has opened a new state-of-the-art facility, developed by Kadans Science Partner, at Sovereign House, Abingdon Science Park, UK. The purpose-built building, including state-of-the-art CL2 wet labs, will support the company’s growth and accelerated development of immuno-oncology therapeutics. They are moving from The BioEscalator in Oxford where they have previously operated from.
MediMab Biotherapeutics’ discovery platform uses advances in systems biology combined with sophisticated immunological solutions to identify significantly improved first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumours. The company was founded in 2020 by Dr Ji Eun Lee with the goal to develop MediMabBio's cooperative research with the Oxford University Hospital for research on the development of new immuno-oncology drugs, alongside strengthening the network with local biopharmaceutical companies. The company has developed pipelines of highly promising novel drugs that aim to overcome the current limitations of cancer immunotherapy.
Abingdon Science Park is a leading life-science research park spanning over 500,000 sq ft, and home to companies such as Genefirst, Sherlock Biosciences, Akamis Bio, Penlon, Scilogica and Oxdevice. MediMab Biotherapeutics will accompany Helix Geospace who moved to Sovereign House in January 2024.
Kadans Science Partner has recently completed on Barton House at Abingdon Science Park. The building totals c.25,000 sq.ft of laboratory space and houses an onsite café that can be used by all of the park occupiers. There is now a shuttle bus service between Didcot Parkway to Abingdon Science Park that is available to all Kadans Science Partner occupiers.
Properties on the Park are jointly leased by specialised science and technology advisors DTRE and Bidwells.
Source: Cambridge Network Limited